Treatment of chronic immune thrombocytopenia in children with romiplostim. Chaturvedi S, McCrae KR (2016) Lancet 388: 4-6 Anti-proliferative effects of T cells expressing a ligand-based chimeric antigen receptor against CD116 on CD34(+) cells of juvenile myelomonocytic leukemia. Nakazawa Y, Matsuda K, Kurata T, Sueki A, Tanaka M, Sakashita K, Imai C, Wilson MH, Koike K (2016) J Hematol Oncol 9: 27 Compound heterozygous c-Mpl mutations in a child with congenital amegakaryocytic thrombocytopenia: functional characterization and a review of the literature. Fox NE, Chen R, Hitchcock I, Keates-Baleeiro J, Frangoul H, Geddis AE (2009) Exp Hematol 37: 495-503 Long-term use of the thrombopoietin-mimetic romiplostim in children with severe chronic immune thrombocytopenia (ITP). Bussel JB, Hsieh L, Buchanan GR, Stine K, Kalpatthi R, Gnarra DJ, Ho RH, Nie K, Eisen M (2015) Pediatr Blood Cancer 62: 208-213
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.